• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射腺苷对低心肌侧支血流模型中心肌再灌注损伤的影响。

Effect of intravenous adenosine on myocardial reperfusion injury in a model with low myocardial collateral blood flow.

作者信息

Norton E D, Jackson E K, Virmani R, Forman M B

机构信息

Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN.

出版信息

Am Heart J. 1991 Nov;122(5):1283-91. doi: 10.1016/0002-8703(91)90567-2.

DOI:10.1016/0002-8703(91)90567-2
PMID:1950990
Abstract

The purpose of this study was to investigate the effects of various doses of adenosine administered intravenously on myocardial reperfusion injury in a model with poor collateral blood flow. New Zealand White rabbits were subjected to 30 minutes of occlusion of the obtuse marginal branch of the left circumflex artery and to 48 hours of reperfusion. Animals were randomized to receive intravenous adenosine in doses of 0.1 mg/min (low), 0.3 mg/min (intermediate), or 0.55 mg/min (high), or an equivalent volume of saline (control) commencing 5 minutes prior to reperfusion and continuing through the first 60 minutes of reperfusion. The area at risk was determined in vivo with Monastral blue dye and the area of necrosis was histologically examined with Masson's trichrome stain. Both the intermediate and high doses of adenosine, but not the low dose, significantly (p less than 0.05) decreased mean blood pressure. However, all three doses of adenosine produced a significant (p less than 0.05) and comparable decrease in infarct size expressed as a percent of area at risk (control, 52.0 +/- 4.6%; low, 35.3 +/- 4.1%; intermediate, 31.7 +/- 4.6%; high, 31.3 +/- 4.6%). Regional myocardial blood flow was significantly increased and coronary vascular resistance decreased by all three doses of adenosine in a subset of animals that did not undergo coronary occlusion (p less than 0.05). This study demonstrates that intravenous administration of nonhypotensive doses of adenosine given during the early reperfusion period attenuates reperfusion injury in a model with poor collateral blood flow.

摘要

本研究的目的是在侧支血流较差的模型中,探讨静脉注射不同剂量腺苷对心肌再灌注损伤的影响。将新西兰白兔的左旋支动脉钝缘支闭塞30分钟,然后再灌注48小时。动物被随机分组,在再灌注前5分钟开始静脉注射剂量为0.1mg/min(低剂量)、0.3mg/min(中等剂量)或0.55mg/min(高剂量)的腺苷,或等量的生理盐水(对照组),并持续至再灌注的前60分钟。用专利蓝染料在体内测定危险区,并用马森三色染色法对坏死区进行组织学检查。中等剂量和高剂量的腺苷可显著降低平均血压(p<0.05),而低剂量则无此作用。然而,所有三种剂量的腺苷均能使梗死面积显著减少(p<0.05),且减少程度相当,梗死面积以危险区面积的百分比表示(对照组为52.0±4.6%;低剂量组为35.3±4.1%;中等剂量组为31.7±4.6%;高剂量组为31.3±4.6%)。在未进行冠状动脉闭塞的部分动物中,所有三种剂量的腺苷均显著增加了局部心肌血流量,并降低了冠状动脉血管阻力(p<0.05)。本研究表明,在早期再灌注期间静脉注射非低血压剂量的腺苷可减轻侧支血流较差模型中的再灌注损伤。

相似文献

1
Effect of intravenous adenosine on myocardial reperfusion injury in a model with low myocardial collateral blood flow.静脉注射腺苷对低心肌侧支血流模型中心肌再灌注损伤的影响。
Am Heart J. 1991 Nov;122(5):1283-91. doi: 10.1016/0002-8703(91)90567-2.
2
Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period.在再灌注早期静脉注射腺苷减轻心肌再灌注损伤。
Circulation. 1991 Jan;83(1):237-47. doi: 10.1161/01.cir.83.1.237.
3
Myocardial reperfusion injury in the canine model after 40 minutes of ischemia: effect of intracoronary adenosine.犬缺血40分钟后心肌再灌注损伤:冠状动脉内注射腺苷的作用
Am Heart J. 1991 Dec;122(6):1561-70. doi: 10.1016/0002-8703(91)90272-j.
4
Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.比马卡林是一种ATP敏感性钾通道开放剂,可模拟缺血预处理的作用,以缩小犬类的梗死面积、减少腺苷释放并降低中性粒细胞功能。
Circulation. 1995 Sep 1;92(5):1236-45. doi: 10.1161/01.cir.92.5.1236.
5
Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon.冠状动脉内注射腺苷减轻犬模型的再灌注损伤:内皮及无复流现象的重要性
Circulation. 1987 Nov;76(5):1135-45. doi: 10.1161/01.cir.76.5.1135.
6
Intracoronary adenosine administered after reperfusion limits vascular injury after prolonged ischemia in the canine model.在犬模型中,再灌注后冠状动脉内给予腺苷可限制长时间缺血后的血管损伤。
Circulation. 1989 Nov;80(5):1388-99. doi: 10.1161/01.cir.80.5.1388.
7
Adenosine infusion during early reperfusion failed to limit myocardial infarct size in a collateral deficient species.在早期再灌注期间输注腺苷未能在侧支循环不足的物种中限制心肌梗死面积。
Cardiovasc Res. 1991 Nov;25(11):943-9. doi: 10.1093/cvr/25.11.943.
8
Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration.冠状动脉内腺苷给药剂量和时间对梗死面积和无复流的限制作用具有关键性影响。
JACC Cardiovasc Interv. 2015 Dec 28;8(15):1990-1999. doi: 10.1016/j.jcin.2015.08.033.
9
Adenosine protects against attenuation of flow reserve and myocardial function after coronary occlusion and reperfusion.腺苷可预防冠状动脉闭塞及再灌注后血流储备和心肌功能的减弱。
Am Heart J. 1994 May;127(5):1201-11. doi: 10.1016/0002-8703(94)90037-x.
10
Reduction in reperfusion-induced myocardial necrosis in dogs by RheothRx injection (poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function.通过注射流变学药物RheothRx(泊洛沙姆188美国国家处方集)减少犬再灌注诱导的心肌坏死,该药物可改变中性粒细胞功能。
Circulation. 1994 Dec;90(6):2964-75. doi: 10.1161/01.cir.90.6.2964.

引用本文的文献

1
A Hydrogel Strategy to Augment Tissue Adenosine to Improve Hindlimb Perfusion.水凝胶策略增强组织腺苷以改善后肢灌注。
Arterioscler Thromb Vasc Biol. 2021 Jun;41(6):e314-e324. doi: 10.1161/ATVBAHA.120.315428. Epub 2021 Apr 22.
2
Characterization of the N-etheno-bridge method to assess extracellular metabolism of adenine nucleotides: detection of a possible role for purine nucleoside phosphorylase in adenosine metabolism.评估腺嘌呤核苷酸细胞外代谢的 N-亚乙基桥方法的特征:嘌呤核苷磷酸化酶在腺苷代谢中可能起作用的检测。
Purinergic Signal. 2020 Jun;16(2):187-211. doi: 10.1007/s11302-020-09699-x. Epub 2020 May 4.
3
Signalling pathways and mechanisms of protection in pre- and postconditioning: historical perspective and lessons for the future.
预处理和后处理中的信号通路与保护机制:历史视角及对未来的启示
Br J Pharmacol. 2015 Apr;172(8):1913-32. doi: 10.1111/bph.12903. Epub 2014 Nov 24.
4
Adenosine and cardioprotection during reperfusion--an overview.腺苷与再灌注期间的心脏保护——综述
Mol Cell Biochem. 2003 Sep;251(1-2):153-9.
5
Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study.急性心肌梗死溶栓治疗后腺苷辅助治疗的左心室功能与心血管事件,心脏并发症腺苷衰减(ATTACC)研究结果
Eur J Clin Pharmacol. 2003 May;59(1):1-9. doi: 10.1007/s00228-003-0564-8. Epub 2003 Mar 18.
6
Attenuation of ischemic liver injury by augmentation of endogenous adenosine.通过增强内源性腺苷减轻缺血性肝损伤
Transplantation. 1997 Jan 27;63(2):217-23. doi: 10.1097/00007890-199701270-00007.
7
Effect of adenosine deaminase inhibition with pentostatin on myocardial stunning in dogs.
Basic Res Cardiol. 1995 Mar-Apr;90(2):176-83. doi: 10.1007/BF00789447.